Last reviewed · How we verify

NCT05217264

Adaptation of High Activity Arthroplasty Score to Turkish

Completed Last updated 27 July 2022
What this trial tests

trial testing Assesment in Arthropathy in 50 participants. Completed in 20 June 2022.

Timeline
3 February 2022
Primary endpoint
1 May 2022
20 June 2022

Quick facts

Lead sponsorHarran University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date3 February 2022
Primary completion1 May 2022
Estimated completion20 June 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Harran University

Who can join

Adults 18 to 65, any sex, with Arthropathy or Surgery--Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objectives of this study were the translation, cross-cultural adaptation, and assessment of the psychometric properties of the Turkish High-Activity Arthroplasty Score (HAAS) in patients with primary TKA.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Psychometric properties of the Turkish high-activity arthroplasty score in TKA patients.
    Yasaci Z, Altay MA, Satis S, Tiras HM. · · 2026 · PMID 41787380 · DOI 10.1186/s12891-026-09561-y

Verify or expand the search:

Other trials of Assesment

Trials testing the same drug.

Other recruiting trials for Arthropathy

Currently open trials in the same condition.

Other Harran University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05217264.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing